Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.61+0.02 (+3.06%)
Close on Nov 17, 2026Market cap $3.44MP/E –Yield –
Imunon operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Imunon's operating cash flow for the twelve months ending Mar 31, 2026 was -$15.03M. For fiscal 2025 it was -$13.90M. The highest annual figure on record is -$7.04M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.90M | – |
| FY2024 | Dec 31, 2024 | -$18.85M | – |
| FY2023 | Dec 31, 2023 | -$19.02M | – |
| FY2022 | Dec 31, 2022 | -$23.10M | – |
| FY2021 | Dec 31, 2021 | -$16.22M | – |
| FY2020 | Dec 31, 2020 | -$15.62M | – |
| FY2019 | Dec 31, 2019 | -$20.26M | – |
| FY2018 | Dec 31, 2018 | -$7.04M | – |
| FY2017 | Dec 31, 2017 | -$16.64M | – |
| FY2016 | Dec 31, 2016 | -$18.38M | – |
| FY2015 | Dec 31, 2015 | -$20.83M | – |
| FY2014 | Dec 31, 2014 | -$21.35M | – |
| FY2013 | Dec 31, 2013 | -$9.53M | – |
| FY2012 | Dec 31, 2012 | -$22.14M | – |
| FY2011 | Dec 31, 2011 | -$22.74M | – |
| FY2010 | Dec 31, 2010 | -$13.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$3.99M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.66M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.42M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.47M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.98M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.79M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.74M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.96M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.95M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.98M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.62M | -192.3% |
| Q3 FY2019 | Sep 30, 2019 | -$4.48M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.54M | – |
| Q4 FY2018 | Dec 31, 2018 | $6.09M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.27M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.21M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.66M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.21M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.11M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.13M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.66M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.72M | – |
| Q2 FY2016 | Jun 30, 2016 | -$4.25M | – |
| Q1 FY2016 | Mar 31, 2016 | -$4.74M | – |
See a number that looks wrong?